To the full analysis
QuidelOrtho stock: growth
QDELQuidelOrtho reported $2.73B in revenue for fiscal 2025, down 1.9% on the prior year, up 10.4% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
18.6%
per year from 2006 to 2025, per share 14.2%
Earnings (Annual rate)
no data
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 10.4% | 30.1% | 18.6% |
| Revenue per share | 0.4% | 21.4% | 14.2% |
| Earnings | no data | no data | no data |
| Earnings per share | no data | no data | no data |
| Free cash flow | no data | no data | no data |
| Free cash flow per share | no data | no data | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $106.02M | $21.72M | $9.76M |
| 2007 | $118.07M | $13.63M | $23.59M |
| 2008 | $128.13M | $18.85M | $24.46M |
| 2009 | $164.28M | $32.88M | $65.74M |
| 2010 | $113.34M | −$11.27M | −$20.77M |
| 2011 | $158.6M | $7.63M | $26.2M |
| 2012 | $155.74M | $4.99M | −$8.09M |
| 2013 | $175.41M | $7.39M | $3.18M |
| 2014 | $182.62M | −$7.07M | $24.45M |
| 2015 | $196.13M | −$6.08M | $19.28M |
| 2016 | $191.6M | −$13.81M | −$94K |
| 2017 | $277.74M | −$8.17M | $10.2M |
| 2018 | $522.29M | $74.18M | $104.66M |
| 2019 | $534.89M | $72.92M | $107.26M |
| 2020 | $1.66B | $810.29M | $564.84M |
| 2021 | $1.7B | $704.2M | $513.15M |
| 2022 | $3.27B | $548.7M | $744.4M |
| 2023 | $3B | −$10.1M | $70.9M |
| 2024 | $2.78B | −$2.05B | −$112.1M |
| 2025 | $2.73B | −$1.13B | −$83M |
Revenue by region
Where QuidelOrtho Corporation generates its revenue.
- North America$1.5B55%
- EMEA$360.7M13%
- China$334.7M12%
- Latin America$252.9M9%
- Other$293.0M11%
“Other” combines smaller regions with revenue the company does not assign to a region. The company split earlier years differently. A history would not be comparable, so only 2025 is shown.
Figures as a table
| 2025 | Share 2025 | |
|---|---|---|
| North America | $1.49B | 54.5% |
| EMEA | $360.7M | 13.2% |
| China | $334.7M | 12.3% |
| Latin America | $252.9M | 9.3% |
| Other | $293M | 10.7% |
| Total revenue | $2.73B | 100% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 28 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 30 Sep 2023)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.